Allspring Global Investments Holdings, LLC
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1890906
CHARLOTTE, NC
Position in XENE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$14,322,693
New position
Shares Held
246,306
first reported quarter
Ownership
0.255%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 40.26170698237152.ToString("F0")%
Shared 0.ToString("F0")%
None 59.73829301762847.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allspring Global Investments Holdings, LLC holds $702,720,315 across 64 Biotechnology names. XENE ranks #11 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
175,311 | $128,020,857 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,793 | $93,236,848 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,707,715 | $73,243,895 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
889,356 | $66,043,575 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
123,760 | $55,263,790 | |
| 6 | INSM |
INSMED Inc
|
282,734 | $46,232,662 | |
| 7 | ASND |
Ascendis Pharma A/S
|
184,224 | $42,137,554 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,497 | $40,561,281 |
All Filings in XENE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,322,693 | 246,306 | Shares | Other | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||